The U.S. Food and Drug Administration on Thursday approved Roche's under-the-skin injection to treat patients with multiple ...

The U.S. Food and Drug Administration on Friday approved Roche's under-the-skin injection to treat patients with multiple ...

Weight loss injections are popular among adults, but a new study suggest they could be useful in fighting childhood obesity, ...

Joplin, who misfired on the potential winning score earlier in overtime, received a long outlet pass from Redwood goalkeeper ...

Shares in Roche dropped to a two-month low on Thursday after an experimental weight-loss pill that carries high market hopes ...

Deutsche Bank downgrades AstraZeneca (AZN) and Roche (RHHBY) after disappointing data for thier key pipeline assets. Read ...

Roche is holding out hopes that its injectable obesity prospect could eventually demonstrate 25% weight loss in late-stage ...

Recently revealed trial results for Roche's experimental weight-management drug suggest Viking Therapeutics is on the right ...

Patients will be able to get a 10 minute injection of the Roche drug, instead of an hours-long infusion. Novartis already has ...

When Roche's Genentech gained approval for Ocrevus in 2017, the first-in- | On the same day that Roche gained an FDA approval ...

Roche (RHHBY) receives FDA approval for a subcutaneous version of cancer immunotherapy Tecentriq developed with Halozyme ...

Roche’s R&D is moving on up. The pharma giant has opened two new high-rises in Basel, Switzerland, according to a Sept. 10 ...